Professor Adam Guastella is the Michael Crouch Chair in Child and Youth Mental Health. His position is based at both Sydney Children’s Hospital at Westmead and the Brain and Mind Centre, University of Sydney. His work aims to build collaborative partnerships between researchers, clinicians, and services to ensure that children and families receive the best available assessments and treatments to support well-being. As part of this role, he is the co-lead of the Child-Neurodevelopment and Mental Health Team for the University of Sydney. This team aims to solve complex problems for children with neurodevelopmental disorders and their families with a team of multi-disciplinary professors across the university. He is also the co-lead for the child bio-informatics hub for the University of Sydney, applying technology application to support well-being and research with families.
Adam Guastella
Professor
Brain and Mind Centre; Children’s Hospital Westmead Clinical School
From this contributor
To accelerate the study of neurodevelopment, we need a transdiagnostic framework
Our tendency to focus on one condition at a time likely silos expertise and services—and obscures critical connections across diagnostic categories.
To accelerate the study of neurodevelopment, we need a transdiagnostic framework
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.